Примери за използване на Other receptors на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Do not block other receptors;
Other receptors can identify oxygen levels in certain bloodstream arteries.
Melatonin does not bid well to other receptors, but Melatonin II does.
Other receptors detect levels of oxygen in certain arteries of the bloodstream.
Bosentan specifically antagonises ET receptors and does not bind to other receptors.
For its processing, other receptors of the stomach are required than in the case of home-made dishes.
It is believed CBD's mechanism of action is mediated by other receptors in the brain and body.
Instead, it activates other receptors, like the vanilloid, adenosine and serotonin receptors. .
This suggests that CBD's mechanism of action is mediated by other receptors in the brain and body.
However, the compounds also target other receptors and activate pathways that may play a role in triggering cardiovascular diseases, she said.
Additionally, the authors caution that because SCBs are chemically different from THC,they may activate other receptors aside from CB1.
Telmisartan does not show affinity for other receptors, including AT2and other less characterised AT receptors. .
But skin deformations also radiate away from this area, down the fingers, and throughout the rest of the hand,activating many other receptors in the process.
The drug does not demonstrate affinity for other receptors, including AO2 and other less well characterized AT receptors. .
Palonosetron is a 5-HT3 receptor antagonist with a strong binding affinity for this receptor andlittle or no affinity for other receptors.
Telmisartan does not show affinity for other receptors, including AT2 and other less characterised AT receptors. .
Actions at other receptors e.g., 5-HT1A, 5-HT1B, 5-HT2C, 5-HT6, 5-HT7, D3, and α2-adrenergic receptors, may also contribute to the clinical effects of asenapine.
Approximately the same picture is observed in other cells of our body with other receptors, which are adapted only for the absorption of a certain type of molecules.
CBD can influence other receptors such as opioid receptors which are known for regulating pain and glycine receptors that are involved in the process of regulating serotonin(the feel-good hormone).
Telmisartan selectively binds to the AT1 receptor anddoes not show affinity for other receptors, including AT2 or other less characterised AT receptors. .
Instead, CBD is thought to influence other receptors, including opioid receptors that regulate pain and glycine receptors involved in the regulation of the"feel-good" hormone serotonin.
As an anti-inflammatory substance,it appears to function via CB2 receptors- but also via other receptors involved in inflammation, reducing the production of inflammatory cytokines(substances that signal the immune system to increase the inflammatory response)(11).
Alternatively, CBD is believed to influence other receptors, including receptors that are opioid regulate pain and glycine receptors mixed up in legislation regarding the“feel-good” hormones serotonin.
Pharmacologically, PCP Phencyclidine powder is a noncompetitive NMDA/glutamate receptor antagonist, butalso interacts with other receptor sites, and may have effects with dopamine, opioid and nicotinic receptors. .
Where synaptic neurotransmitters are released by axon terminals to have a fast-acting impact on other receptor neurons, neuromodulators diffuse across a larger area and are more slow-acting.
Pharmacologically, PCP is a noncompetitive NMDA N-methyl-D-aspartate receptor antagonist and glutamate receptor antagonist, butalso interacts with other receptor sites, and may have effects with dopamine, opioid and nicotinic receptors. .
In addition, midostaurin inhibits several other receptor tyrosine kinases such as PDGFR(platelet-derived growth factor receptor) or VEGFR2(vascular endothelial growth factor receptor 2), as well as members of the serine/threonine kinase family PKC(protein kinase C).
And where the synaptic neurotransmitters will be released by the axon terminals for having the fast acting impact at other receptor neurons, and neuromodulators diffuse over the larger area as well as are slow-acting.